ADCYAP1 and bacterial infectious disease: Previous research involving teleostean PACAP-38 has focused on assessing its antimicrobial activity when directly dosing aquatic pathogens (46), the growth/immunomodulatory effects of the peptide alone (47–49), or how viral/bacterial infection can influence gene expression of the peptide and its associated receptors (50).